271
Views
22
CrossRef citations to date
0
Altmetric
Theme: ADHD - Special Report

Does soy-based infant formula cause ADHD? Update and public policy considerations

Pages 395-407 | Published online: 09 Jan 2014

References

  • Crinella FM. Does soy-based infant formula cause ADHD? Expert Rev. Neurother.3, 89–92 (2003).
  • Polancyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry164, 942–948 (2007).
  • Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition. World Psychiatry2, 104–113 (2003).
  • Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J. Atten. Disord.11, 106–113 (2007).
  • Milberger S, Biederman J, Faraone SV, Murphy J, Tsuang MT. Attention deficit hyperactivity disorder and comorbid disorders. Am. J. Psychiatry152, 1793–1799 (1995).
  • Wender P. Minimal Brain Dysfunction in Children. Wiley-Interscience, NY, USA (1971).
  • Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust. NZ J. Psychiatry25, 277–283 (1991).
  • LaHoste GJ, Swanson JM, Wigal SB et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry1, 121–124 (1996).
  • Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr. Opin. Neurobiol.8, 263–271 (1998).
  • Grady D, Moyzis R, Swanson JM. Molecular genetics and attention in ADHD. Clin. Neurosci. Res.5, 265–272 (2005).
  • MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up; 24 month outcomes of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Pediatrics113, 754–761 (2004).
  • Swanson JM, Elliott BR, Greenhill LL et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J. Am. Acad. Child Adolesc. Psychiatry46, 1014–1026 (2007).
  • Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder. J. Dev. Behav. Pediatr.23, S37–S45 (2002).
  • Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J. Paediatr. Child Health41, 23–26 (2005).
  • Stubblefield TG, Wray JA, Parry TS. Utilization of alternative therapies in attention deficit hyperactivity disorder. J. Paediatr. Child Health35, 450–453 (1999).
  • Rush B. An enquiry into the influence of physical causes upon the moral faculties. Annual oration. Presented at: Meeting of The American Philosophical Society. PA, USA, 27 February 1786.
  • Feingold B. Why Your Child is Hyperactive. Random House, NY, USA (1973).
  • Rucklidge JJ, Johnstone J, Kaplan B. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev. Neurother.9, 461–476 (2009).
  • Gesch CB, Hammond SM, Hampson SE et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners: randomised, placebo-controlled trial. Br. J. Psychiatry181, 22–28 (2002).
  • Zaalberg A, Nijman H, Bulten E et al. Aggressive behavior. Food Behav. Res.36, 117–126 (2010).
  • Walsh WJ, Glab LB, Haakenson ML. Reduced violent behavior following biochemical therapy. Physiol. Behav.82, 835–839 (2004).
  • Schneider JS, Decamp E, Koser AJ et al. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res.118, 222–231 (2006).
  • Schneider JS, Decamp E, Clark K et al. Effects of chronic manganese exposure on working memory in non-human primates. Brain Res.1258, 86–95 (2008).
  • Aschner M, Guilarte TR, Schneider JS, Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol.221, 131–147 (2007).
  • Dorner K, Dziadzka S, Bohn A et al. Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow’s milk formulas. Br. J. Nutr.61, 559–572 (1989).
  • Lonnerdal B. Manganese nutrition of infants. In: Manganese in Health and Disease. Klimis-Rvantzis D (Ed.). CRC Press, FL, USA, 175–191 (1994).
  • Pihl RO, Parks M. Hair element content in learning disabled children. Science198, 204–206 (1977).
  • Marlowe M, Bliss L. Hair element concentrations and young children’s behavior at school and home. J. Orthomol. Med.9, 1–12 (1993).
  • Cawte J. Psychiatric sequelae of manganese exposure in the adult, foetal and neonatal nervous systems. Aust. NZ J. Psychiatry19, 211–217 (1985).
  • Zhang G, Liu D, He P. Effects of manganese on learning abilities in school children. Chin. J. Prev. Med.29, 156–158 (1995).
  • Crinella FM, Cordova E, Ericson JE. Head hair levels of manganese in children with attention deficit disorder and aggression. Presented at: 15th Annual Meeting of the International Society for Neurotoxicology. Little Rock, AR, USA, 3 April 1997.
  • Collip PJ, Chen SY, Maitinsky S. Manganese in infant formulas and learning disability. Ann. Nutrit. Metabol.27, 488–494 (1983).
  • Prohaska JR. Functions of trace elements in brain metabolism. Physiol. Rev.67, 858–901 (1987).
  • Erikson KM, Dorman DC, Lash LH, Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol. Sci.97, 459–466 (2007).
  • Donaldson J, Barbeau A. Metal ions in neurology and psychiatry. Manganese neurotoxicity: possible clues to the etiology of human brain disorders. In: Neurology and Neurobiology. Gabay S, Harris J, Ho BT (Eds). Alan R Liss Inc., NY, USA, 259–285 (1985).
  • Genro JP, Kielling C, Rohde LA, Hutz MH. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev. Neurother.10, 587–601 (2010).
  • Cotzias GC. Manganese in health and disease. Physiol. Rev.38, 503–532 (1958).
  • Iregren A. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol. Teratol.12, 673–675 (1990).
  • Roels H, Lauwerys R, Buchet JP et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am. J. Ind. Med.11, 307–327 (1987).
  • Klos KJ, Chandler M, Kumar N et al. Neuropsychological profiles of manganese neurotoxicity. Eur. J. Neurol.13, 1139–1141 (2006).
  • Lucchini RG, Martin CJ, Doney BC. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. Neuromol. Med.11, 311–321 (2009).
  • Duhart HM, Lipe GW, Sobotka T, Slikker W, Ali SF. Pre- and post-natal exposure to manganese chloride on reactive oxygen species (ROS) in difference regions of rat brain. Neurotox. Teratol.16, 326–332 (1994).
  • Malecki EA, Deveny AG, Beard JL, Connor JR. Transferrin response in normal and iron-deficient mice heterozygotic for hypotransferrinemia: effects on iron and manganese accumulation. Biometals11, 265–276 (1998).
  • Chandra SV, Shukla GS. Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J. Neurochem.36, 683–687 (1981).
  • Subhash MN, Padmashree TS. Regional distribution of dopamine B-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese. Fed. Chem. Toxicol.28, 567–570 (1990).
  • Davidson L, Lonnerdal B, Sandstrom B, Kunz C, Keen CL. Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr.119, 1461–1464 (1989).
  • Zhang K, Tarazi FI, Davids E, Baldessarini RJ. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology26, 625–633 (2002).
  • Oner G, Senturk UK. Reversibility of manganese-induced learning defect in rats. Food Chem. Toxicol.33, 559–563 (1995).
  • Gray L, Lackey JW. Multivariate analysis of the effects of manganese on the reproductive physiology and behavior of the male house mouse. J. Toxicol. Environ. Health6, 861–867 (1980).
  • Nachtman JP, Tubben RE, Commissaris RL. Behavioral effects of chronic manganese administration in rats: locomotor activity studies. Neurobehav. Toxicol. Teratol.8, 711–715 (1986).
  • Ponzoni S, Guimaraes FS, Del Bel EA, Garcia-Cairasco N. Behavioral effects of intranigral microinjections of manganese chloride: interaction with nitric oxide. Prog. Neuro-Psychopharmacol. Biol. Psychiatry24, 307–325 (2000).
  • Donaldson J. Manganese neurotoxicity: clues to the pathophysiology of brain disorders. Presented at: International Conference on Heavy Metal Toxicity. Irvine, CA, USA, 15 March 2001.
  • Donaldson J, La Bella FS, Gesser D. Enhanced autooxidation of dopamine as a possible basis of manganese neurotoxicity. Neurotoxicology2, 53–64 (1981).
  • Garcia SL, Gellein K, Syversen T, Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat brain. Toxicol. Sci.92, 516–525 (2006).
  • Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem. Int.41, 271–277 (2001).
  • Erikson K, Aschner M. Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology23, 595–602 (2001).
  • Spranger M, Schwab LS, Desiderato S, Bonman E, Krieger D, Fandrey J. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism? Exp. Neurol.149, 277–283 (1998).
  • Boje KM, Orora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res.587, 250–256 (1992).
  • Chao CC, Hju S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol.149, 2736–2741 (1992).
  • Erikson KM, Dorman DC, Lash LH, Aschner M. Persistent alterations in biomarkers of oxidative stress resulting from combined in utero and neonatal manganese inhalation. Biol. Trace Elem. Res.104, 151–164 (2005).
  • Zheng W, Zhao Q, Slavkovich GV, Aschner M, Graziano J. Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res.833, 125–132 (1999).
  • Aschner M, Vrana KE, Zheng W. Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology20, 173–180 (1999).
  • Eriksson H, Magiste K, Plantin LO et al. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol.61, 46–52 (1987).
  • Eriksson H, Gillberg PG, Aquilonius SM, Hedstrom KG, Heilbronn E. Receptor alterations in manganese intoxicated monkeys. Arch. Toxicol.66, 359–364 (1992).
  • Eriksson H, Tedroff J, Thuomas KA et al. Manganese induced brain lesions in Macaca fasicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch. Toxicol.66, 403–407 (1992).
  • Shinotoh H, Snow BJ, Hewitt KA et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology45, 1199–1204 (1995).
  • Van Bogaert L, Dallemagne MJ Approches expérimentales des troubles nerveux du manganisme. J. Psychiatry Neurol.111, 60–89 (1943).
  • Huang CC, Lu CS, Chu NS et al. Progression after chronic manganese exposure. Neurology43, 1479–1483 (1993).
  • Gwiazda RH, Lee D, Sheridan J, Smith DR. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology95, 1–8 (2002).
  • Reaney SH, Bench G, Smith DR. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol. Sci.93, 114–124 (2006).
  • Stokinger HE. Manganese. In: Patty’s Industrial Hygiene and Toxicology: Toxicology Vol. 2A (Third Revised Edition). Clayton GD, Clayton FE (Eds). Wiley, NY, USA, 1749–1769 (1987).
  • Lonnerdal B, Keen CL, Ohtake M, Tamura T. Iron, zinc, copper and manganese in infant formulas. Am. J. Dis. Child.137, 433–437 (1983).
  • Bell JG, Keen CL, Lonnerdal B. Higher retention of manganese in suckling than in adult rats is not due to maturation differences in manganese uptake by rat small intestine. J. Toxicol. Environ. Health26, 387–398 (1989).
  • Keen CL, Ensuensa JL, Lonnerdal B, Zidenberg-Cherr S. Manganese. In: Encyclopedia of Human Nutrition (2nd Edition). Caballero B, Allen L, Prentice A (Eds). Elsevier/Academic Press, Oxford, UK, 217–225 (2005).
  • Erikson KM, Thompson K, Aschner J, Aschner M. Manganese neurotoxicity: a focus on the neonate. Pharmacol. Ther.113, 369–377 (2007).
  • American Academy of Pediatrics. Soy protein-based formulas: recommendations for use in infant feeding. Am. J. Pediatr.101, 148–153 (1998).
  • Krachler M, Rossipal E. Concentrations of trace elements in extensively hydrolysed infant formulae and their estimated daily intakes. Ann. Nutr. Metab.44, 68–74 (2000).
  • Stasny D, Vogel RS, Picciano MF. Manganese intake and serum manganese concentration of human milk-fed and formula-fed infants. Am. J. Clin. Nutr.39, 872–878 (1984).
  • Ljung K, Vahter M. Time to re-evaluate the guideline value for manganese in drinking water? Environ. Health Perspect.115, 1533–1538 (2007).
  • Tran TT, Chowanadisai W, Crinella FM et al. Effect of manganese supplementation of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology23, 635–643 (2002).
  • Tran TT, Crinella FM, Chicz-Demet A et al. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology23, 645–651 (2002).
  • Kern C, Stanwood GD, Smith DR. Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficit associated with altered dopamine receptor and transporter levels. Synapse64, 363–378 (2010).
  • McDougall SA, Reichel CM, Farley CM. Postnatal manganese exposure alters dopamine transporter function in adult rats: potential impact on nonassociative and associative processes. Neuroscience154, 848–860 (2008).
  • Golub M, Hogrefe CE, Germann SL et al. Neurobehavioral evaluation of rhesus monkey infants fed cow’s milk formula, soy formula, or soy formula with added manganese. Neurotoxicol. Teratol.27, 615–627 (2005).
  • Barkley RA. Behavioral inhibition, sustained attention, and executive function: constructing a unifying theory of ADHD. Psychol. Bull.121, 65–94 (1997).
  • Gwiazda R, Lucchini R, Smith D. Adequacy and consistency of animal studies to evaluate the neurotoxicity of manganese at chronic low level manganese exposure in humans. J. Toxicol. Environ. Health Part A,70, 594–605 (2007).
  • Integrated Risk Information System (IRIS). Health Risk Assessment of Manganese. Environmental Criteria and Assessment Office, Cincinnati, OH, USA (1993).
  • Ericson JE, Crinella FM, Clark-Stewart KA et al. Prenatal manganese levels linked to childhood behavioral disinhibition. Neurotoxicol. Teratol.29, 181–187 (2006).
  • NICHD Early Child Care Research Network. Nonmaternal care and family factors in early development: an overview of the NICHD study of early child care. J. Appl. Develop. Psychol.22, 457–492 (2001).
  • Lee KM, Appleton J, Cooke M, Keenan F, Sawicka-Kapusta K. Use of laser ablation-inductively coupled plasma-mass spectrometry to provide element versus time profiles in teeth. Anal. Chim. Acta395, 179–185 (1999).
  • Lochner F, Appleton J, Keenan F, Cooke M. Multi-element profiled of human deciduous teeth by laser ablation-inductively coupled plasma-mass spectrometry. Anal. Chim. Acta401, 299–306 (1999).
  • Mena I. The role of manganese in human disease. Ann. Clin. Lab. Sci.4, 487–491 (1974).
  • Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am. J. Clin. Nutr.71, S1280–S1284 (2000).
  • Davidsson L, Cederblad A, Lonnerdal B, Sandstrom B. The effect of individual dietary components on manganese absorption in man. Am. J. Clin. Nutr.54, 1065–1070 (1992).
  • Golub MS, Hogrefe CE, Germann SL, Capitanio J, Lozoff B. Behavioral consequences of developmental iron deficiency in infant rhesus monkey. Neurotoxicol. Teratol.28, 3–17 (2006).
  • Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ. Health Perspect.115, 122–127 (2007).
  • US Department of Health and Human Services. Healthy People 2010: Conference Edition. Vols. I and II. US Government Printing Office, Washington, DC, USA (2000).
  • Li R, Zhao Z, Mokdad A, Barker L, Grummer-Strawn L. Prevalence of breastfeeding in the United States: the 2001 National Immunization Survey. Pediatrics111, 1198–1201 (2003).
  • Ryan AS, Zhou W. Lower breastfeeding rates persist among the special supplemental nutrition program for women, infants and children participants, 1978–2003. Pediatrics117, 1136–1146 (2006).
  • Li R, Rock VJ, Grummer-Strawn L. Changes in public attitudes toward breastfeeding in the United States. 1999–2003. J. Am. Dietetic Assoc.107, 122–127 (2007).
  • Ip S, Chung M, Raman G et al. breastfeeding and maternal and infant health outcomes in developed countries. In: Evidence Report/Technology Assessment No. 153. Agency for Healthcare Research and Quality, Rockville, MD, USA, 1–186 (2007).
  • Bartick M, Stueibe A, Shealy KR, Walker M, Grummer-Strawn LM. Closing the quality gap: promoting evidence-based breastfeeding care in the hospital. Pediatrics124, 793–802 (2009).
  • Anderson JS, Johnston BM, Remley DT. Breastfeeding and cognitive development: a meta-analysis. Am. J. Clin. Nutr.70, 525–535 (1999).
  • Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet339, 261–264 (1992).
  • McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr.82, 281–295 (2005).
  • Caspi A, Williams B, Kim-Cohen J et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. PNAS104, 18860–18865 (2007).
  • Badger TM, Gilchrist JM, Pivik RT et al. The health implications of soy infant formula. Am. J. Clin. Nutr.89(Suppl.), S1668–S1672 (2009).
  • Jing H, Gilchrist JM, Badger TM, Pivik RT. A longitudinal study of differences in electroencephalographic activity among breastfed, milk-formula-fed and soy formula fed infants during the first year of life. Early Hum. Dev.86, 119–125 (2010).
  • Gillman M. Developmental origins of health and disease. N. Engl. J. Med.353, 1848–1850 (2005).
  • Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science305, 1733–1736 (2004).
  • Faroane SV, Doyle AE. The nature and heritability of attention deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin. N. Am.10, 290–316 (2001).
  • Larsson H, Lichtenstein P, Larsson JO. Genetic contributions to the development of ADHD subtypes from childhood to adolescence. J. Am. Acad. Child Adolesc. Psychiatry45, 973–981 (2006).
  • Swanson JM, Sunohara GA, Kennedy JL. Association of the dopamine receptor D4 (DRD4) with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry3, 38–41 (1998).
  • Swanson JM, Posner M, Fusella J, Wasdell M, Sommer T, Fan J. Genes and attention deficit hyperactivity disorder. Curr. Psychiatry Rep.3, 92–100 (2001).
  • Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Ped. Endocrin. Rev.3, 104–113 (2005).
  • Sutcliffe AG, Derom C. Follow-up of twins: health, behaviour, speech, language outcomes and implications for parents. Early Hum. Dev.82, 379–386 (2006).
  • Ingelfinger JR. Prematurity and the legacy of intrauterine stress. N. Engl. J. Med.356, 2093–2095 (2007).
  • McLean C, Ferriero D. Mechanisms of hypoxic–ischemic injury in the term infant. Semin. Perinatol.28, 425–432 (2004).
  • Sandman CA, Davis EP. Gestational stress influences cognition and behavior. Future Neurol.5, 675–690 (2010).
  • Green NS. Risks of birth defects and other adverse outcomes associated with assisted reproductive technology. Pediatrics114, 256–259 (2004).
  • Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N. Engl. J. Med.346, 725–730 (2002).
  • Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet. Gynecol.103, 551–563 (2004).
  • Stromberg B, Dahlquist G, Ericson A et al. Neurological sequelae in children born after in-vitro fertilisation: a population based study. Lancet359, 461–465 (2002).
  • Dennett DC. Darwin’s Dangerous Idea: Evolution and the Meanings of Life. Allen Lane, London, UK (1995).
  • McCann D, Barrett A, Cooper A et al. Food additives and hyperactive behaviours in 3-year old and 8/9-year-old children in the community: a randomized, double-blinded, placebo-controlled trial. Lancet370, 1560–1567 (2007).
  • Leno M (Chair). Is there a relationship between elevated manganese levels and violent behavior? California Assembly Committee on Public Safety, Sacramento, CA, USA (2004).
  • Lien L, Lien N, Heyerdal S, Thoreson M, Bjertness E. Consumption of soft drinks and hyperactivity, mental distress and conduct problems among adolescents in Oslo Norway. Am. J. Public Health96, 1815–1820 (2006).
  • Woolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA274, 1617–1621 (1995).
  • Benton D. Sucrose and behavioral problems. Crit. Rev. Food Sci. Nutr.48, 385–401 (2008).
  • McNemar Q. At random: sense and nonsense. Am. Psychol.15, 553–557 (1960).
  • Edwards AL. Experimental Design in Psychological Research. Rinehart, NY, USA (1950).
  • Lozoff B, Klein NK, Nelson EC, McClish DK, Manuel M, Chacon ME. Behavior of infants with iron-deficiency anemia. Child Dev.69, 24–36 (1998).
  • Murphy VA, Rosenberg JM, Smith QR, Rapoport SI. Elevation of brain manganese in calcium deficient rats. Neurotoxicology12, 255–264 (1991).
  • Rossander-Hulthen L, Brune M, Sandstrom B, Lonnerdal B, Hallberg L. Competitive inhibition of iron absorption by manganese and zinc in humans. Am. J. Clin. Nutr.54, 152–156 (1991).
  • Wedekind KJ, Murphy MR, Baker DH. Manganese turnover in chicks as affected by excess phosphorus consumption. J. Nutr.121, 1035–1041 (1991).
  • Barkley RA, Smith KM, Fischer M, Bradfor V. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 BP VNTR) in hyperactive and normal children followed to adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet.141B, 487–498 (2006).
  • Rozin P. Disorders of food selection. The compromise of pleasure. Ann. NY Acad. Sci.575, 376–386 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.